glp-1 osteoporosis weight loss drugs could increase risk of and gout, new research finds Do GLP-1 Drugs Cause Bone

Clinical trials reveal that 10-15% of participants taking GLP-1 medications like Wegovy or Mounjaro qualify as non-responders, losing less than 5% of their body weight

Multicentre study on prevalence of endocrine complications in thalassaemia major

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the active ingredient in both Wegovy and Ozempic

The normal levels may vary slightly between different labs but generally below 140pmol/L is considered a deficiency

In summary, you can expect: regular clinic visits and blood tests (IGF-1 and others) every few months initially

Patience is your best friend here